Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

11.11.21	Lilly announces winners of inaugural Leonard Award, a global program celebrating 100 years of innovation in diabetes care (PR Newswire)
09.11.21	Lilly to Participate in Wolfe Research Virtual Healthcare Conference (PR Newswire)
09.11.21	OLUMIANT® Long-Term Safety Profile Established Up to 9.3 Years in Integrated Analysis of More Than 3,700 Patients with Rheumatoid Arthritis (PR Newswire)
05.11.21	Jardiance® shows consistent cardio-renal benefits in adults with heart failure with left ventricular ejection fraction over 40% regardless of chronic kidney disease status (PR Newswire)
04.11.21	Loxo Oncology at Lilly Announces Details of Presentations at the 2021 American Society of Hematology (ASH) Annual Meeting (PR Newswire)
03.11.21	Eli Lilly-Aktie dennoch in Grün: EU-Arzneimittelbehörde stoppt Prüfung von COVID-Medikament von Eli Lilly (AWP) Die EU-Arzneimittelbehörde EMA hat das Prüfverfahren eines COVID-Medikaments des Herstellers Eli Lilly gestoppt.» mehr
02.11.21	Lilly To Supply 614K Additional Doses Of Bamlanivimab And Etesevimab To The US (RTTNews)
02.11.21	Lilly to supply 614,000 additional doses of bamlanivimab and etesevimab to the U.S. Government for the treatment or post-exposure prevention of COVID-19 (PR Newswire)
01.11.21	Lilly to Participate in Bernstein's Second Annual Operational Decisions Conference (PR Newswire)
28.10.21	Additional Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Published in the Annals of Oncology (PR Newswire)
26.10.21	MÄRKTE USA/Überzeugende Berichtssaison sorgt für neue Rekordstände (Dow Jones)
26.10.21	Eli Lilly-Aktie klettert: Eli Lilly kann auch im dritten Quartal deutlich zulegen (AWP) Der US-Pharmakonzern Eli Lilly wächst dank guter Geschäfte etwa mit dem Insulin Trulicity oder dem Schuppenflechtemittel Taltz weiter kräftig.» mehr
26.10.21	MÄRKTE USA/Rekordjagd hält an - Berichtssaison überzeugt weiter (Dow Jones)
26.10.21	MÄRKTE USA/Wall Street startet mit neuen Rekordhochs (Dow Jones)
26.10.21	MÄRKTE USA/Wall Street zum Start mit Aufschlägen erwartet (Dow Jones)
26.10.21	Lilly Lifts FY21 Adj. EPS, Revenue View Above Market - Quick Facts (RTTNews)
26.10.21	Eli Lilly And Co. Profit Drops In Q3 (RTTNews)
26.10.21	Lilly Reports Robust Third-Quarter 2021 Financial Results as Pipeline Success Strengthens Future Growth Potential (PR Newswire)
26.10.21	Ausblick: Eli Lilly and zieht Bilanz zum abgelaufenen Quartal (finanzen.net) So sehen die Prognosen der Experten für die Eli Lilly and-Bilanz aus.» mehr
19.10.21	Lilly : Phase 3 Tirzepatide Results Show Superior A1C And Body Weight Reductions In Type 2 Diabetes (RTTNews)
19.10.21	Tirzepatide results published in The Lancet show superior A1C and body weight reductions compared to insulin glargine in adults with type 2 diabetes with increased cardiovascular risk (PR Newswire)
18.10.21	Lilly Declares Fourth-Quarter 2021 Dividend (PR Newswire)
14.10.21	Lilly Announces Updated Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Presented at ESMO Virtual Plenary and Simultaneously Published in the Annals of Oncology (PR Newswire)
13.10.21	Eli Lilly: FDA Approves Verzenio In Adjuvant Treatment Of HR+ HER2- Early Breast Cancer (RTTNews)
13.10.21	FDA Approves Verzenio® (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer (PR Newswire)
12.10.21	Lilly Confirms Date and Conference Call for Third-Quarter 2021 Financial Results Announcement (PR Newswire)
12.10.21	COVAX Exercises Option To Purchase 176.5 Mln Addl Doses Of Moderna COVID-19 Vaccine In H1 2022 (RTTNews)
11.10.21	Erste Schätzungen: Eli Lilly and präsentiert Quartalsergebnisse (finanzen.net) Eli Lilly and legt die jüngste Bilanz offen. Was Analysten erwarten.» mehr
07.10.21	Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics (PR Newswire)
07.10.21	Sonoco To Implement Price Increase For Uncoated Recycled Paperboard (RTTNews)
04.10.21	Ready for the Challenge? Boehringer Ingelheim and Eli Lilly and Company Launch First Ever Online Game on Cardio-Renal-Metabolic Conditions for Healthcare Professionals (PR Newswire)
01.10.21	At Week 104, 75% of Patients with Ulcerative Colitis Taking Mirikizumab Maintained Symptomatic Remission in Phase 2 Study (PR Newswire)
30.09.21	Lilly, Incyte Present Detailed Results From OLUMIANT BRAVE-AA1, BRAVE-AA2 Trials In Alopecia Areata (RTTNews)
30.09.21	OLUMIANT® Significantly Improved Hair Regrowth to At Least 80% Scalp Coverage as Early as 24 Weeks Across First Completed Phase 3 Studies for Alopecia Areata (PR Newswire)
30.09.21	Lilly Reports Positive Results From Two SURPASS-3 Sub-studies Of Tirzepatide In Type 2 Diabetes (RTTNews)
30.09.21	Lilly's tirzepatide led to greater improvements in liver fat content compared to insulin degludec in adults with type 2 diabetes in SURPASS-3 MRI sub-study (PR Newswire)
30.09.21	Lilly's tirzepatide led to greater time in range compared to insulin degludec in adults with type 2 diabetes in SURPASS-3 CGM sub-study (PR Newswire)
29.09.21	Lilly and Susan G. Komen® Partner to Address Disparities in Breast Cancer Outcomes Experienced By Black Women (PR Newswire)
29.09.21	FDA Expands Lilly's Erbitux Label With Braftovi For Treatment Of Metastatic Colorectal Cancer (RTTNews)
28.09.21	FDA Expands Lilly's ERBITUX® (cetuximab) Label with Combination of BRAFTOVI® (encorafenib) for the Treatment of BRAF V600E Mutation-Positive Metastatic Colorectal Cancer (CRC) after Prior Therapy (PR Newswire)
28.09.21	Lilly Cuts List Price Of Insulin Lispro Injection In U.S. Again, Effective Jan. 1 (RTTNews)
28.09.21	Lilly again reduces list price of Insulin Lispro Injection as latest change to affordability options (PR Newswire)
27.09.21	New Data from Verzenio® (abemaciclib) monarchE Study to Be Featured in ESMO Virtual Plenary (PR Newswire)
27.09.21	Lilly Recalls One Lot Of GLUCAGON Emergency Kit (RTTNews)
25.09.21	Eli Lilly and Company Issues Voluntary Nationwide Recall of One Lot of GLUCAGON® Emergency Kit Due to Loss of Potency (PR Newswire)
21.09.21	EU-Kommission sichert sich Eli Lillys COVID-19-Medikament - Aktie schwächer (AWP) Die EU-Kommission hat einen Rahmenvertrag über die gemeinsame Anschaffung eines COVID-19-Medikaments des Pharmaunternehmens Eli Lilly abgeschlossen.» mehr
21.09.21	Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities (PR Newswire)
21.09.21	Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19 (PR Newswire)
21.09.21	Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities and Removal of the Note Caps... (PR Newswire)
17.09.21	MÄRKTE USA/Wall Street im Bann von China und "Hexensabbat" (Dow Jones)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

18:00		Novartis-Aktie: Was Analysten im November vom Papier halten
18:00		Analysten sehen für Bayer-Aktie Luft nach oben
18:00		November 2024: So haben Analysten ihre Einstufung der Merck-Aktie angepasst
29.11.24		Pluszeichen in New York: Letztendlich Gewinne im Dow Jones
29.11.24		Starker Wochentag in New York: Dow Jones mit Kursplus
29.11.24		Gute Stimmung in New York: Börsianer lassen Dow Jones mittags steigen
29.11.24		SMI-Handel aktuell: SMI zum Handelsende auf grünem Terrain
29.11.24		Gewinne in Europa: Euro STOXX 50 präsentiert sich zum Ende des Freitagshandels fester

18:00

Novartis-Aktie: Was Analysten im November vom Papier halten

18:00

Analysten sehen für Bayer-Aktie Luft nach oben

18:00

November 2024: So haben Analysten ihre Einstufung der Merck-Aktie angepasst

29.11.24

Pluszeichen in New York: Letztendlich Gewinne im Dow Jones

29.11.24

Starker Wochentag in New York: Dow Jones mit Kursplus

29.11.24

Gute Stimmung in New York: Börsianer lassen Dow Jones mittags steigen